W J Lee1, L Sobrin2, M H Kang1, M Seong1, Y J Kim1, J-H Yi3, J W Miller2, H Y Cho4. 1. Department of Ophthalmology, Hanyang University College of Medicine, Hanyang University Guri Hospital, Guri-City, South Korea. 2. Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Uveitis and Retina Services, Boston, MA, USA. 3. Department of Nephrology, Hanyang University College of Medicine, Hanyang University Guri Hospital, Guri-City, South Korea. 4. 1] Department of Ophthalmology, Hanyang University College of Medicine, Hanyang University Guri Hospital, Guri-City, South Korea [2] Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Uveitis and Retina Services, Boston, MA, USA.
Abstract
PURPOSE: To assess the value of diabetic retinopathy (DR) severity as a possible predictive prognostic factor for the progression of chronic kidney disease (CKD). PATIENTS AND METHODS: Retrospective cohort study. Patients (51) who were initially diagnosed with DR and CKD were enrolled and their medical records were evaluated. The following ophthalmic factors were assessed by fluorescein angiography at the initial visit: area of capillary nonperfusion, presence of neovascularization and vitreous hemorrhage, and DR grade. The effect of these factors on CKD progression over the 2-year period of the study, defined as doubling of serum creatinine or the development of end-stage renal disease requiring dialysis or renal transplant, was evaluated. RESULTS: The study included 51 patients with DR and CKD; of these, 11 patients (21.6%) were found to have proliferative DR (PDR) and seven patients (13.7%) had high-risk PDR at baseline. Patients with ischemic DR, who showed extensive capillary nonperfusion (≥ 10 optic disc areas) in the retina, had a greater risk for CKD progression (hazard ratio = 6.64; P = 0.002). CONCLUSION: We found that extensive capillary nonperfusion in the retina greatly increased the risk of progression of CKD in patients with DR. This suggests that the retina and the kidney may have shared risk factors for microvascular disease secondary to diabetes mellitus, and emphasizes the need for a team approach to diabetes care.
PURPOSE: To assess the value of diabetic retinopathy (DR) severity as a possible predictive prognostic factor for the progression of chronic kidney disease (CKD). PATIENTS AND METHODS: Retrospective cohort study. Patients (51) who were initially diagnosed with DR and CKD were enrolled and their medical records were evaluated. The following ophthalmic factors were assessed by fluorescein angiography at the initial visit: area of capillary nonperfusion, presence of neovascularization and vitreous hemorrhage, and DR grade. The effect of these factors on CKD progression over the 2-year period of the study, defined as doubling of serum creatinine or the development of end-stage renal disease requiring dialysis or renal transplant, was evaluated. RESULTS: The study included 51 patients with DR and CKD; of these, 11 patients (21.6%) were found to have proliferative DR (PDR) and seven patients (13.7%) had high-risk PDR at baseline. Patients with ischemic DR, who showed extensive capillary nonperfusion (≥ 10 optic disc areas) in the retina, had a greater risk for CKD progression (hazard ratio = 6.64; P = 0.002). CONCLUSION: We found that extensive capillary nonperfusion in the retina greatly increased the risk of progression of CKD in patients with DR. This suggests that the retina and the kidney may have shared risk factors for microvascular disease secondary to diabetes mellitus, and emphasizes the need for a team approach to diabetes care.
Authors: Juan E Grunwald; Judith Alexander; Gui-Shuang Ying; Maureen Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker; Kathleen McWilliams; Joan C Lo; Alan Go; Raymond Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie; Bernard G Jaar Journal: Arch Ophthalmol Date: 2012-09
Authors: William F Keane; Barry M Brenner; Dick de Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert Toto Journal: Kidney Int Date: 2003-04 Impact factor: 10.612
Authors: Ji Won Min; Hyung Duk Kim; Sang Yoon Park; Jun Hyuk Lee; Jae Hyun Park; Anna Lee; Ho Ra; Jiwon Baek Journal: Invest Ophthalmol Vis Sci Date: 2020-12-01 Impact factor: 4.799
Authors: Elysse S Tom; Steven S Saraf; FuPeng Wang; Qinqin Zhang; Gautam Vangipuram; Christine P Limonte; Ian H de Boer; Ruikang K Wang; Kasra A Rezaei Journal: J Ophthalmol Date: 2020-11-30 Impact factor: 1.909
Authors: Antonio Rodríguez-Poncelas; Xavier Mundet-Tudurí; Sonia Miravet-Jiménez; Aina Casellas; Joan F Barrot-De la Puente; Josep Franch-Nadal; Gabriel Coll-de Tuero Journal: PLoS One Date: 2016-02-17 Impact factor: 3.240